• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解代谢合并症的非酒精性脂肪性肝炎对成年人的影响:一项真实世界的定性研究。

Understanding the impact of non-alcoholic steatohepatitis with metabolic comorbidities on adults: a real-world qualitative study.

机构信息

Eli Lilly and Company, Indianapolis, IN, USA.

Evidera, Bethesda, MD, USA.

出版信息

Curr Med Res Opin. 2024 Apr;40(4):665-676. doi: 10.1080/03007995.2024.2319820. Epub 2024 Feb 29.

DOI:10.1080/03007995.2024.2319820
PMID:38363353
Abstract

OBJECTIVE

Limited real-world evidence exists to better understand the patient experience of living with symptoms and impacts of non-alcoholic steatohepatitis (NASH). This study aimed to (1) describe patient-reported perspectives of NASH symptoms and impacts on patients' daily lives and (2) develop a patient-centered conceptual NASH model.

METHODS

A cross-sectional study using semi-structured qualitative interviews was conducted among adults (≥18 years) in the United States living with NASH. Eligible participants were diagnosed with NASH, had mild to advanced fibrosis (F1-F3), and no other causes of liver disease. The interview guide was informed by a targeted literature review (TLR) to identify clinical signs, symptoms, impacts, and unmet treatment needs of NASH. Participants described their experiences and perspectives around NASH and the symptoms, symptom severity/bother, and impact of NASH on their daily activities. Interviews were audio-recorded and transcribed verbatim for coding and thematic analysis.

RESULTS

Twenty participants (age: 42.4 years; female: 50.0%) were interviewed. Participants discussed their experience with NASH symptoms (most frequent: fatigue [75.0%]; weakness/lethargy [70.0%]) and impacts (most frequent: physical and psychological/emotional [70.0% each]; dietary [68.4%]). Participants considered most symptoms to be moderately severe or severe and moderately or highly bothersome. Findings from the TLR and qualitative interviews were incorporated into a conceptual model that describes patient-reported symptoms and impacts of NASH, clinical signs, risk factors, and unmet treatment needs.

CONCLUSION

Our study provides insights into patients' perspectives of NASH symptoms and their impact on their daily lives. These findings may guide patient-physician conversations, supporting patient-centered treatment decisions and disease management.

摘要

目的

关于非酒精性脂肪性肝炎(NASH)患者的症状和影响,现有真实世界证据有限,难以深入了解患者的实际体验。本研究旨在:(1)描述患者报告的 NASH 症状和对日常生活的影响;(2)建立以患者为中心的 NASH 概念模型。

方法

采用横断面研究,对美国患有 NASH 的成年人(≥18 岁)进行半结构式定性访谈。合格参与者的诊断为 NASH,存在轻度至晚期纤维化(F1-F3),且无其他肝病病因。访谈指南的制定参考了目标文献综述(TLR),以确定 NASH 的临床体征、症状、影响和未满足的治疗需求。参与者描述了他们对 NASH 及其症状、症状严重程度/困扰、对日常活动的影响的体验和看法。访谈内容进行音频记录并逐字转录,以便进行编码和主题分析。

结果

共对 20 名参与者(年龄:42.4 岁;女性:50.0%)进行了访谈。参与者讨论了他们的 NASH 症状体验(最常见:疲劳[75.0%];乏力/无精打采[70.0%])和影响(最常见:身体和心理/情绪[70.0%],饮食[68.4%])。参与者认为大多数症状为中度至重度,且具有中度至高度困扰性。TLR 和定性访谈的结果被纳入一个概念模型,该模型描述了患者报告的 NASH 症状及其对日常生活的影响、临床体征、危险因素和未满足的治疗需求。

结论

本研究深入了解了患者对 NASH 症状及其对日常生活影响的看法。这些发现可能有助于患者与医生的沟通,支持以患者为中心的治疗决策和疾病管理。

相似文献

1
Understanding the impact of non-alcoholic steatohepatitis with metabolic comorbidities on adults: a real-world qualitative study.了解代谢合并症的非酒精性脂肪性肝炎对成年人的影响:一项真实世界的定性研究。
Curr Med Res Opin. 2024 Apr;40(4):665-676. doi: 10.1080/03007995.2024.2319820. Epub 2024 Feb 29.
2
Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study.了解非酒精性脂肪性肝炎(NASH)患者的偏好和未满足的需求:来自定性在线公告板研究的见解。
Adv Ther. 2019 Feb;36(2):478-491. doi: 10.1007/s12325-018-0856-0. Epub 2018 Dec 13.
3
A qualitative patient interview study to understand the experience of patients with nonalcoholic steatohepatitis.一项定性的患者访谈研究,旨在了解非酒精性脂肪性肝炎患者的体验。
Hepatol Commun. 2023 Feb 9;7(3):e0036. doi: 10.1097/HC9.0000000000000036. eCollection 2023 Mar 1.
4
Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.非酒精性脂肪性肝炎的诊断和治疗:从患者和初级保健医生的角度进行的横断面调查。
Ann Med. 2023 Dec;55(1):2211349. doi: 10.1080/07853890.2023.2211349.
5
Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.真实世界环境中非酒精性脂肪性肝炎患者的临床特征和管理:对 Ipsos NASH 治疗监测数据库的分析。
BMC Gastroenterol. 2023 May 19;23(1):160. doi: 10.1186/s12876-023-02794-4.
6
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study.非酒精性脂肪性肝炎(NASH-CHECK)患者报告结局测量工具的开发:定性研究结果。
Patient. 2021 Sep;14(5):533-543. doi: 10.1007/s40271-020-00485-w. Epub 2020 Dec 18.
7
Thematic analysis to explore patients' experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives.主题分析探索长新冠患者的体验:症状和日常生活影响的概念模型。
BMJ Open. 2024 Jan 17;14(1):e076992. doi: 10.1136/bmjopen-2023-076992.
8
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study.西班牙非酒精性脂肪性肝炎(NASH)相关的晚期纤维化:一项 Delphi 研究结果。
Gastroenterol Hepatol. 2024 Apr;47(4):337-346. doi: 10.1016/j.gastrohep.2023.06.005. Epub 2023 Jun 19.
9
Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study.从患者角度理解重症肌无力的症状负担及影响:一项定性研究
Neurol Ther. 2023 Feb;12(1):107-128. doi: 10.1007/s40120-022-00408-x. Epub 2022 Nov 2.
10
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.

引用本文的文献

1
Cultural and Molecular Factors Predisposed to Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.易患非酒精性脂肪性肝病和2型糖尿病的文化及分子因素。
Nutrients. 2025 May 26;17(11):1797. doi: 10.3390/nu17111797.
2
Nonalcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis emerging market: Preparing managed care for early intervention, equitable access, and integrating the patient perspective.非酒精性脂肪性肝炎/代谢相关脂肪性肝病新兴市场:为早期干预、公平获得和整合患者视角做好管理式医疗准备。
J Manag Care Spec Pharm. 2024 Sep;30(9-a Suppl):S1-S13. doi: 10.18553/jmcp.2024.30.9-a.s1.